CRO & Clinical Services

Biocrates is a metabolomics-focused life science supplier providing standardized, quantitative mass spectrometry-based kits, software, and services for metabolic phenotyping. Headquartered in Innsbruck, Austria, the company’s portfolio enables robust measurement of hundreds to over a thousand metabolites across many biochemical classes, supporting biomarker discovery, clinical, nutritional, and systems biology research. Its mission is to make metabolomics accessible and reproducible for pharma, biotech, and

Crown Bioscience is a global oncology-focused CRO providing discovery, preclinical, and translational services in oncology and immuno-oncology. Headquartered in California and part of JSR Life Sciences, it offers extensive PDX, organoid, CDX, and IO murine model collections, biomarker and bioanalysis platforms, and CAP/CLIA-certified labs to support predictive, clinically relevant oncology R&D.

Bruker is a global manufacturer of high-performance scientific instruments and analytical and diagnostic solutions for life science, pharma, materials and industrial markets. Its portfolio spans NMR, MS, X-ray, microscopy and spectroscopy platforms, supported by applications, consumables and advanced customer services to maximize uptime and productivity.

Cambridge Consultants is a deep tech innovation and consulting company within Capgemini that develops new-to-the-world technologies, products and services for life sciences, healthcare and biotechnology. They combine engineering, physics, chemistry, microfluidics, molecular biology and AI to deliver precision health, biotechnology and intelligent drug delivery solutions for start-ups, scale-ups and enterprises.

Cayman Chemical is a private life science supplier founded in 1980 and headquartered in Ann Arbor, Michigan. The company offers assay kits, antibodies, biochemicals, proteins, and reference standards alongside contract research services including custom synthesis and analytical testing to support pharmaceutical, biotech, academic, and government research globally.

TrakCel is a Cardiff-based software company providing OCELLOS, a Salesforce-powered cell and gene therapy orchestration platform supporting 20+ therapy programs across 300+ sites in 11 countries with 3,700+ users.

Cell Microsystems is a privately held biotechnology company based in Research Triangle Park, North Carolina, that develops platforms for single-cell and small colony workflows. Its portfolio includes the CellRaft AIR System, BioFlux shear flow systems, the CERO 3D bioreactor, and advanced lab services, supporting applications from CRISPR editing to organoid and cell line development.

Cell Sonics (Cellsonics) is a life-science supplier offering SimpleFlow, an enzyme-free acoustic tissue dissociation platform for single-cell sample prep. Based in San Jose, California, the company focuses on high-yield, high-viability, biologically faithful single-cell suspensions to improve downstream flow cytometry and single-cell RNA-seq analyses.

CellarisBio is a private San Diego–based company providing MICRO‑TAG® cellular target engagement technology for drug discovery. It offers reagent kits and collaborative services that quantify ligand–target interactions in intact cells using real‑time and temperature‑series fluorescence readouts, compatible with standard qPCR instruments and validated across more than 100 drug targets.

Cellectricon is a private Swedish neuroscience services company specializing in customized in vitro neurobiology for drug discovery. It supports pharma and biotech teams with basic research, target and lead discovery, technology transfer and neurotoxicity testing using advanced neuronal models and high-content functional readouts to accelerate and de‑risk CNS pipelines.

Cellectricon is a Mölndal, Sweden-based provider of customized in vitro neurobiology services for early-stage neuroscience drug discovery. Its portfolio spans basic research, target and lead discovery, technology transfer and neurotoxicity testing using advanced in vitro models and novel technologies to support pharma and biotech CNS programs.

Cell Microsystems is a private biotechnology tools company in Durham, North Carolina, focused on platforms for single-cell isolation, 3D culture, and shear-flow–based cell models. Its portfolio includes the CellRaft AIR System, BioFlux Shear Flow Systems, the CERO 3D Cell Culture & Bioreactor, and advanced lab services that support CRISPR, stem cell, organoid, and cell line development workflows.

Cencora is a global pharmaceutical solutions organization with strong cold-chain packaging, logistics, and warehousing capabilities that support temperature-sensitive products from clinical development through commercialization. It provides specialized packaging, labeling, and 3PL services alongside broader distribution, commercialization, and patient access solutions for manufacturers and healthcare providers worldwide.

Cencora PharmaLex is a global pharma consulting and regulatory services provider founded in 1994, employing 3,000+ professionals across 60+ offices. It delivers end-to-end lifecycle support including regulatory affairs, pharmacovigilance, clinical development, CMC services, MedTech regulatory, and market access consulting for pharmaceutical, biotech, and medical device companies. Acquired by Cencora in 2023.

Cleanroom Microbiology Solutions (AnalytiChem UK, formerly Cherwell) provides prepared microbiological media, air samplers, EM consumables and calibration services for pharmaceutical and cleanroom environments. Its Redipor® ISO 9001-certified facility delivers standard and bespoke solutions for EU GMP Annex 1-compliant environmental monitoring and process validation across pharma manufacturing, radiopharmacy and NHS hospital pharmacies.

BioPharmaSpec is a global CRO specializing in structural, physicochemical and biophysical characterization of biopharmaceuticals using advanced mass spectrometry and chromatographic techniques. It supports discovery and preclinical development of monoclonal antibodies, ADCs, gene therapies, oligonucleotides and other biologics with ICH Q6B-aligned analytical services and impurity profiling from laboratories in the UK, EU and US.

Cyagen Biosciences is a global CRO specializing in genetically engineered rodent models, custom cell lines, viral packaging and integrated preclinical studies for drug discovery and translational research. With large KO/cKO and humanized mouse libraries, AAALAC-accredited SPF facilities, and platforms such as HUGO-GT™ and HUGO-Ab™, Cyagen supports pharma, biotech and academic customers from target validation through IND-enabling preclinical validation.

Cyprotex ADME-Tox Solutions, part of Evotec, provides in vitro and in silico ADME, PK and predictive toxicology services across discovery and preclinical development. Its unique platforms (eCiphr Cardio, eCiphr Neuro, CellCiphr Premier) and modeling tools support human-relevant predictions of exposure, efficacy and safety for pharmaceutical, biotech and chemical clients.

DEBRA Research is the global, non-profit research arm of DEBRA Austria dedicated to translational research and clinical development of therapies for Epidermolysis Bullosa (EB). It funds and co-develops EB treatment programs, invests in biotech partners, and builds specialized clinical trial infrastructure to move promising EB therapies from lab to patients.

Artios Pharma is a clinical-stage biotechnology company focused on DNA Damage Response (DDR)-based cancer therapeutics, including the ATR inhibitor alnodesertib and the Polθ inhibitor ART6043. Supported by its proprietary DcoDeR platform and a preclinical DDRi-ADC portfolio, Artios targets replication stress and DDR defects in solid tumors to deliver first- and best-in-class oncology treatments.

Dassault Systèmes is a global innovation and software company providing the 3DEXPERIENCE platform, virtual twin technology and industrial AI to life sciences and healthcare organizations. Its pharmaceutical and biotech solutions enable end‑to‑end digital transformation from R&D to manufacturing, embedding compliance, quality and traceability while accelerating data‑driven drug development and sustainable product innovation.

Lifebit is a federated data intelligence platform that pioneers Trusted Research Environments for life sciences and biomedical data. It allows pharma, governments and research organizations to analyze sensitive, population-scale health and genomic data in-place, across borders and infrastructures, with strong privacy, security and compliance. The platform accelerates cancer and rare disease discovery, target validation and translational insights from large biobank and clinico-genomic datasets.

Dolomite Product Line is a discontinued microfluidics line now treated as legacy end-of-support by Unchained Labs. Buyers should verify service status, spare-part availability, and documentation access before relying on it for ongoing lab operations.

Certara is a global, public life-science company providing biosimulation software, AI-driven modeling, and expert consulting across the entire drug development lifecycle. It supports discovery, preclinical, clinical, regulatory, and market access with predictive, evidence-based solutions that help optimize trial design, dosing, safety, and submissions. Buyers use Certara’s technology and services to accelerate development, de-risk portfolios, and demonstrate therapy value.